Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Nextleaf Solutions Ltd.

A pioneering force in the cannabis industry, driving innovation in extraction and life science technology.

 

Bullboard - Investor Discussion Forum Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Healthcare Cannabis Health Care
Nextleaf Solutions Ltd. is a cannabis processor with a portfolio of federally regulated emerging consumer brands, market validated cannabis derivative products, and high-potency bulk ingredients. The Company’s multi-patented, highly automated, closed loop extraction, and distillation technology sets the global standard for processing cannabis at scale. The Company manufactures over 80 different... see more

Bullboard (CSE:OILS)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Comment by shnepson Nov 23, 2023 12:12pm

RE:Interesting someone mentioned creeper on another board...

One player that may fall into that category is our previous debenture holder ATB Capital Markets. Here is a quote from their 2023 cannabis outlook - "we believe investors should focus on ...more  
126
Discussion
Post by Adventurouson Nov 23, 2023 11:40am

Shareholder Rights Plan

Now the question is: Does Nextleaf management thinks that the year-end results it is about to release are so great that they might gather some takeover interest in the Canada-USA investment community ...more  
132
Post by billybonkon Nov 23, 2023 10:11am

Interesting someone mentioned creeper on another board...

It does appear since my last postings, Nextleaf is gaining traction in the profit area.  I've avoided posting since the bullboard is generally quiet these days. However, I should note ...more  
158
Discussion
Post by Dude51on Nov 22, 2023 7:11am

What not to like, I ask?

Why is there so much interest if this was a BS stock? Some folk want to buy 407,000 shares @ 5 cents. These are shorts hoping you will sell. Just look at the financials this should be 3 quarters in a ...more  
114
Comment by signreaderon Nov 20, 2023 6:37pm

RE:RE:RE:RE:So Financial Statements due out again end of this month.

According to the CEO of Tilray, don't hold your breath on the drug reschedule as it is not the same as being fully legal. Furthermore it will not open flood gates to over the border activites just ...more  
103
Discussion
Comment by Dude51on Nov 20, 2023 4:37pm

RE:RE:RE:So Financial Statements due out again end of this month.

Well genius, most of us read the finacials of a company. Try it. GL
34
Discussion
Post by Dude51on Nov 20, 2023 4:36pm

Tic Tok, bye by 6 cents. Just look at the financials?

https://www.marijuanamoment.net/senator-pushes-dea-to-act-with-great-urgency-to-reschedule-marijuana/ Before end of year we could be @ $1.00 easily. What's are product? Well we take garbage leaf ...more  
120
Comment by stealthcton Nov 20, 2023 9:09am

RE:RE:So Financial Statements due out again end of this month.

2023 is almost over and still waiting for fins? How do you guys hold on with your shares?
42
Discussion
Post by Dude51on Nov 17, 2023 5:59pm

Time to eat crow.

That 90 day deadline blah blah blah for DEA to respond to HSS, that's crapp. It could still happen next week. I can not see it, Republicans would have to agree on something and that just aint ...more  
141
Post by Dude51on Nov 17, 2023 5:37pm

So Financial Statements due out again end of this month.

Who ever is keeping this stock under 6 cents tik tok... GL to everyone else
97
Discussion
Post by Dude51on Nov 15, 2023 11:16am

Just a note: DEA has to respond to HSS request to reshedule

pot from shedule 1 to shedule 3. From the day of the request to yea or na from the DEA is 90 days. That's the law from my understanding. That day is November 27, so that leaves exactly 7 more ...more  
146
Post by Dude51on Nov 14, 2023 4:41pm

One thing about OILS that I have noticed even today I

noticed it. NO ONE IS SELLING. WHY? Just look at the financials, don’t take my word for it as I am biased as an investor. GL
66
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with C.OILS

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube


BRANDS HIGHLIGHTS & INSIGHTS EXTRACTION TECHNOLOGY SERVICES TEAM MEDIA VIRTUAL TOURS

Investor Presentation

View the Presentation

Investment Opportunity

  • Market Leadership with patented extraction and distillation technology offering significant efficiencies and higher purity levels over competing technologies
     
  • Debt free and four consecutive years of positive gross revenue. Reported fiscal YE 2023 gross revenue of $9.96MM with a gross profit of $2.3MM
     
  • Untapped domestic growth across various market segments, and the ability to scale production without additional capital expenditure
     
  • Backed by 19 U.S. patents and over 75 global patents provides a solid foundation for future growth and potential licensing opportunities

Primary Extraction

Distillation

Manufacturing: Softgels

The Vault

more...

Facebook

Contact Us